調査レポート | • レポートコード：QYR2104Z5110 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、筋肉減少症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（蛋白質添加物、カルシウムサプリメント、その他）、用途別市場規模（オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・筋肉減少症治療の市場動向 ・企業の競争状況、市場シェア ・筋肉減少症治療の種類別市場規模（蛋白質添加物、カルシウムサプリメント、その他） ・筋肉減少症治療の用途別市場規模（オンライン薬局、小売薬局） ・筋肉減少症治療の北米市場規模2016-2027（アメリカ、カナダ） ・筋肉減少症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・筋肉減少症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・筋肉減少症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・筋肉減少症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Nestlé、Pfizer、Amway、By-health、Usana、A&Z Pharmaceutical、GlaxoSmithKline、Bayer、H&H、Blackmores、Zhendong Group） ・結論 |
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
China is the largest consumption region of Sarcopenia Treatment, with market share nearly 30.83%. The second largest market is United States; following China with the market share of 24.48%.
Market Analysis and Insights: Global Sarcopenia Treatments Market
The global Sarcopenia Treatments market size is projected to reach US$ 3459.4 million by 2026, from US$ 2516.3 million in 2019, at a CAGR of 4.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sarcopenia Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sarcopenia Treatments market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sarcopenia Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sarcopenia Treatments market.
Global Sarcopenia Treatments Scope and Market Size
Sarcopenia Treatments market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sarcopenia Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Protein Supplement
Calcium Supplement
Other
The proportion of protein supplement in 2018 is about 57%.
Segment by Application
Online Pharmacies
Retail Pharmacies
The most of sarcopenia treatments is sales through retail pharmacies, and the market share of that is about 66% in 2018.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
Amway
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sarcopenia Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Protein Supplement
1.2.3 Calcium Supplement
1.2.4 Other
1.3 Market by Application
1.3.1 Global Sarcopenia Treatments Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sarcopenia Treatments Market Perspective (2016-2027)
2.2 Sarcopenia Treatments Growth Trends by Regions
2.2.1 Sarcopenia Treatments Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sarcopenia Treatments Historic Market Share by Regions (2016-2021)
2.2.3 Sarcopenia Treatments Forecasted Market Size by Regions (2022-2027)
2.3 Sarcopenia Treatments Industry Dynamic
2.3.1 Sarcopenia Treatments Market Trends
2.3.2 Sarcopenia Treatments Market Drivers
2.3.3 Sarcopenia Treatments Market Challenges
2.3.4 Sarcopenia Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sarcopenia Treatments Players by Revenue
3.1.1 Global Top Sarcopenia Treatments Players by Revenue (2016-2021)
3.1.2 Global Sarcopenia Treatments Revenue Market Share by Players (2016-2021)
3.2 Global Sarcopenia Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sarcopenia Treatments Revenue
3.4 Global Sarcopenia Treatments Market Concentration Ratio
3.4.1 Global Sarcopenia Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sarcopenia Treatments Revenue in 2020
3.5 Sarcopenia Treatments Key Players Head office and Area Served
3.6 Key Players Sarcopenia Treatments Product Solution and Service
3.7 Date of Enter into Sarcopenia Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sarcopenia Treatments Breakdown Data by Type
4.1 Global Sarcopenia Treatments Historic Market Size by Type (2016-2021)
4.2 Global Sarcopenia Treatments Forecasted Market Size by Type (2022-2027)
5 Sarcopenia Treatments Breakdown Data by Application
5.1 Global Sarcopenia Treatments Historic Market Size by Application (2016-2021)
5.2 Global Sarcopenia Treatments Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sarcopenia Treatments Market Size (2016-2027)
6.2 North America Sarcopenia Treatments Market Size by Type
6.2.1 North America Sarcopenia Treatments Market Size by Type (2016-2021)
6.2.2 North America Sarcopenia Treatments Market Size by Type (2022-2027)
6.2.3 North America Sarcopenia Treatments Market Size by Type (2016-2027)
6.3 North America Sarcopenia Treatments Market Size by Application
6.3.1 North America Sarcopenia Treatments Market Size by Application (2016-2021)
6.3.2 North America Sarcopenia Treatments Market Size by Application (2022-2027)
6.3.3 North America Sarcopenia Treatments Market Size by Application (2016-2027)
6.4 North America Sarcopenia Treatments Market Size by Country
6.4.1 North America Sarcopenia Treatments Market Size by Country (2016-2021)
6.4.2 North America Sarcopenia Treatments Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Sarcopenia Treatments Market Size (2016-2027)
7.2 Europe Sarcopenia Treatments Market Size by Type
7.2.1 Europe Sarcopenia Treatments Market Size by Type (2016-2021)
7.2.2 Europe Sarcopenia Treatments Market Size by Type (2022-2027)
7.2.3 Europe Sarcopenia Treatments Market Size by Type (2016-2027)
7.3 Europe Sarcopenia Treatments Market Size by Application
7.3.1 Europe Sarcopenia Treatments Market Size by Application (2016-2021)
7.3.2 Europe Sarcopenia Treatments Market Size by Application (2022-2027)
7.3.3 Europe Sarcopenia Treatments Market Size by Application (2016-2027)
7.4 Europe Sarcopenia Treatments Market Size by Country
7.4.1 Europe Sarcopenia Treatments Market Size by Country (2016-2021)
7.4.2 Europe Sarcopenia Treatments Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sarcopenia Treatments Market Size (2016-2027)
8.2 Asia-Pacific Sarcopenia Treatments Market Size by Type
8.2.1 Asia-Pacific Sarcopenia Treatments Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sarcopenia Treatments Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sarcopenia Treatments Market Size by Type (2016-2027)
8.3 Asia-Pacific Sarcopenia Treatments Market Size by Application
8.3.1 Asia-Pacific Sarcopenia Treatments Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sarcopenia Treatments Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sarcopenia Treatments Market Size by Application (2016-2027)
8.4 Asia-Pacific Sarcopenia Treatments Market Size by Region
8.4.1 Asia-Pacific Sarcopenia Treatments Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sarcopenia Treatments Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sarcopenia Treatments Market Size (2016-2027)
9.2 Latin America Sarcopenia Treatments Market Size by Type
9.2.1 Latin America Sarcopenia Treatments Market Size by Type (2016-2021)
9.2.2 Latin America Sarcopenia Treatments Market Size by Type (2022-2027)
9.2.3 Latin America Sarcopenia Treatments Market Size by Type (2016-2027)
9.3 Latin America Sarcopenia Treatments Market Size by Application
9.3.1 Latin America Sarcopenia Treatments Market Size by Application (2016-2021)
9.3.2 Latin America Sarcopenia Treatments Market Size by Application (2022-2027)
9.3.3 Latin America Sarcopenia Treatments Market Size by Application (2016-2027)
9.4 Latin America Sarcopenia Treatments Market Size by Country
9.4.1 Latin America Sarcopenia Treatments Market Size by Country (2016-2021)
9.4.2 Latin America Sarcopenia Treatments Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sarcopenia Treatments Market Size (2016-2027)
10.2 Middle East & Africa Sarcopenia Treatments Market Size by Type
10.2.1 Middle East & Africa Sarcopenia Treatments Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sarcopenia Treatments Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sarcopenia Treatments Market Size by Type (2016-2027)
10.3 Middle East & Africa Sarcopenia Treatments Market Size by Application
10.3.1 Middle East & Africa Sarcopenia Treatments Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sarcopenia Treatments Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sarcopenia Treatments Market Size by Application (2016-2027)
10.4 Middle East & Africa Sarcopenia Treatments Market Size by Country
10.4.1 Middle East & Africa Sarcopenia Treatments Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sarcopenia Treatments Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Sarcopenia Treatments Introduction
11.1.4 Abbott Laboratories Revenue in Sarcopenia Treatments Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Nestlé
11.2.1 Nestlé Company Details
11.2.2 Nestlé Business Overview
11.2.3 Nestlé Sarcopenia Treatments Introduction
11.2.4 Nestlé Revenue in Sarcopenia Treatments Business (2016-2021)
11.2.5 Nestlé Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Sarcopenia Treatments Introduction
11.3.4 Pfizer Revenue in Sarcopenia Treatments Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Amway
11.4.1 Amway Company Details
11.4.2 Amway Business Overview
11.4.3 Amway Sarcopenia Treatments Introduction
11.4.4 Amway Revenue in Sarcopenia Treatments Business (2016-2021)
11.4.5 Amway Recent Development
11.5 By-health
11.5.1 By-health Company Details
11.5.2 By-health Business Overview
11.5.3 By-health Sarcopenia Treatments Introduction
11.5.4 By-health Revenue in Sarcopenia Treatments Business (2016-2021)
11.5.5 By-health Recent Development
11.6 Usana
11.6.1 Usana Company Details
11.6.2 Usana Business Overview
11.6.3 Usana Sarcopenia Treatments Introduction
11.6.4 Usana Revenue in Sarcopenia Treatments Business (2016-2021)
11.6.5 Usana Recent Development
11.7 A&Z Pharmaceutical
11.7.1 A&Z Pharmaceutical Company Details
11.7.2 A&Z Pharmaceutical Business Overview
11.7.3 A&Z Pharmaceutical Sarcopenia Treatments Introduction
11.7.4 A&Z Pharmaceutical Revenue in Sarcopenia Treatments Business (2016-2021)
11.7.5 A&Z Pharmaceutical Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Sarcopenia Treatments Introduction
11.8.4 GlaxoSmithKline Revenue in Sarcopenia Treatments Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Sarcopenia Treatments Introduction
11.9.4 Bayer Revenue in Sarcopenia Treatments Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 H&H
11.10.1 H&H Company Details
11.10.2 H&H Business Overview
11.10.3 H&H Sarcopenia Treatments Introduction
11.10.4 H&H Revenue in Sarcopenia Treatments Business (2016-2021)
11.10.5 H&H Recent Development
11.11 Blackmores
11.11.1 Blackmores Company Details
11.11.2 Blackmores Business Overview
11.11.3 Blackmores Sarcopenia Treatments Introduction
11.11.4 Blackmores Revenue in Sarcopenia Treatments Business (2016-2021)
11.11.5 Blackmores Recent Development
11.12 Zhendong Group
11.12.1 Zhendong Group Company Details
11.12.2 Zhendong Group Business Overview
11.12.3 Zhendong Group Sarcopenia Treatments Introduction
11.12.4 Zhendong Group Revenue in Sarcopenia Treatments Business (2016-2021)
11.12.5 Zhendong Group Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Sarcopenia Treatments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Protein Supplement
Table 3. Key Players of Calcium Supplement
Table 4. Key Players of Other
Table 5. Global Sarcopenia Treatments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sarcopenia Treatments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Sarcopenia Treatments Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Sarcopenia Treatments Market Share by Regions (2016-2021)
Table 9. Global Sarcopenia Treatments Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Sarcopenia Treatments Market Share by Regions (2022-2027)
Table 11. Sarcopenia Treatments Market Trends
Table 12. Sarcopenia Treatments Market Drivers
Table 13. Sarcopenia Treatments Market Challenges
Table 14. Sarcopenia Treatments Market Restraints
Table 15. Global Sarcopenia Treatments Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Sarcopenia Treatments Market Share by Players (2016-2021)
Table 17. Global Top Sarcopenia Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sarcopenia Treatments as of 2020)
Table 18. Ranking of Global Top Sarcopenia Treatments Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Sarcopenia Treatments Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sarcopenia Treatments Product Solution and Service
Table 22. Date of Enter into Sarcopenia Treatments Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sarcopenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Sarcopenia Treatments Revenue Market Share by Type (2016-2021)
Table 26. Global Sarcopenia Treatments Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Sarcopenia Treatments Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Sarcopenia Treatments Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Sarcopenia Treatments Revenue Market Share by Application (2016-2021)
Table 30. Global Sarcopenia Treatments Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Sarcopenia Treatments Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Sarcopenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Sarcopenia Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Sarcopenia Treatments Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Sarcopenia Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Sarcopenia Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Sarcopenia Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Sarcopenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Sarcopenia Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Sarcopenia Treatments Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Sarcopenia Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Sarcopenia Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Sarcopenia Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Sarcopenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Sarcopenia Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Sarcopenia Treatments Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Sarcopenia Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Sarcopenia Treatments Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Sarcopenia Treatments Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Sarcopenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Sarcopenia Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Sarcopenia Treatments Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Sarcopenia Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Sarcopenia Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Sarcopenia Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Sarcopenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Sarcopenia Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Sarcopenia Treatments Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Sarcopenia Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Sarcopenia Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Sarcopenia Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Sarcopenia Treatments Product
Table 65. Abbott Laboratories Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 66. Abbott Laboratories Recent Development
Table 67. Nestlé Company Details
Table 68. Nestlé Business Overview
Table 69. Nestlé Sarcopenia Treatments Product
Table 70. Nestlé Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 71. Nestlé Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Sarcopenia Treatments Product
Table 75. Pfizer Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Amway Company Details
Table 78. Amway Business Overview
Table 79. Amway Sarcopenia Treatments Product
Table 80. Amway Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 81. Amway Recent Development
Table 82. By-health Company Details
Table 83. By-health Business Overview
Table 84. By-health Sarcopenia Treatments Product
Table 85. By-health Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 86. By-health Recent Development
Table 87. Usana Company Details
Table 88. Usana Business Overview
Table 89. Usana Sarcopenia Treatments Product
Table 90. Usana Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 91. Usana Recent Development
Table 92. A&Z Pharmaceutical Company Details
Table 93. A&Z Pharmaceutical Business Overview
Table 94. A&Z Pharmaceutical Sarcopenia Treatments Product
Table 95. A&Z Pharmaceutical Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 96. A&Z Pharmaceutical Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 100. GlaxoSmithKline Recent Development
Table 101. Bayer Company Details
Table 102. Bayer Business Overview
Table 103. Bayer Sarcopenia Treatments Product
Table 104. Bayer Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 105. Bayer Recent Development
Table 106. H&H Company Details
Table 107. H&H Business Overview
Table 108. H&H Sarcopenia Treatments Product
Table 109. H&H Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 110. H&H Recent Development
Table 111. Blackmores Company Details
Table 112. Blackmores Business Overview
Table 113. Blackmores Sarcopenia Treatments Product
Table 114. Blackmores Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 115. Blackmores Recent Development
Table 116. Zhendong Group Company Details
Table 117. Zhendong Group Business Overview
Table 118. Zhendong Group Sarcopenia Treatments Product
Table 119. Zhendong Group Revenue in Sarcopenia Treatments Business (2016-2021) & (US$ Million)
Table 120. Zhendong Group Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sarcopenia Treatments Market Share by Type: 2020 VS 2027
Figure 2. Protein Supplement Features
Figure 3. Calcium Supplement Features
Figure 4. Other Features
Figure 5. Global Sarcopenia Treatments Market Share by Application: 2020 VS 2027
Figure 6. Online Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Sarcopenia Treatments Report Years Considered
Figure 9. Global Sarcopenia Treatments Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Sarcopenia Treatments Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Sarcopenia Treatments Market Share by Regions: 2020 VS 2027
Figure 12. Global Sarcopenia Treatments Market Share by Regions (2022-2027)
Figure 13. Global Sarcopenia Treatments Market Share by Players in 2020
Figure 14. Global Top Sarcopenia Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sarcopenia Treatments as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Sarcopenia Treatments Revenue in 2020
Figure 16. Global Sarcopenia Treatments Revenue Market Share by Type (2016-2021)
Figure 17. Global Sarcopenia Treatments Revenue Market Share by Type (2022-2027)
Figure 18. North America Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Sarcopenia Treatments Market Share by Type (2016-2027)
Figure 20. North America Sarcopenia Treatments Market Share by Application (2016-2027)
Figure 21. North America Sarcopenia Treatments Market Share by Country (2016-2027)
Figure 22. United States Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Sarcopenia Treatments Market Share by Type (2016-2027)
Figure 26. Europe Sarcopenia Treatments Market Share by Application (2016-2027)
Figure 27. Europe Sarcopenia Treatments Market Share by Country (2016-2027)
Figure 28. Germany Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Sarcopenia Treatments Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Sarcopenia Treatments Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Sarcopenia Treatments Market Share by Region (2016-2027)
Figure 38. China Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Sarcopenia Treatments Market Share by Type (2016-2027)
Figure 46. Latin America Sarcopenia Treatments Market Share by Application (2016-2027)
Figure 47. Latin America Sarcopenia Treatments Market Share by Country (2016-2027)
Figure 48. Mexico Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Sarcopenia Treatments Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Sarcopenia Treatments Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Sarcopenia Treatments Market Share by Country (2016-2027)
Figure 54. Turkey Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Sarcopenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 58. Nestlé Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 60. Amway Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 61. By-health Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 62. Usana Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 63. A&Z Pharmaceutical Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 66. H&H Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 67. Blackmores Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 68. Zhendong Group Revenue Growth Rate in Sarcopenia Treatments Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の筋肉減少症健康管理市場規模・現状・予測（2021年-2027年） Research is now focusing on the role of physical activity, nutrition, and potential future medications that may be used to treat or prevent sarcopenia. Market Analysis and Insights: Global Sarcopenia Healthcare Market The global Sarcopenia Healthcare market size is projected to reach US$ XX million …- 世界のアルファマンノシドーシス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alpha Mannosidosis Treatments Market The global Alpha Mannosidosis Treatments market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界の統合失調症治療市場規模・現状・予測（2021年-2027年） Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schizophrenia. Market Analysis and Insights: Global Schizophr…
- 世界の歯内療法治療市場規模・現状・予測（2021年-2027年） Endodontics Treatments are for the infected pulp of a tooth which results in the elimination of infection and the protection of the decontaminated tooth from future microbial invasion. Market Analysis and Insights: Global Endodontics Treatments Market The global Endodontics Treatments market size is…
- 世界の発作治療市場規模・現状・予測（2021年-2027年） An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain. Increasing prevalence of neurological disorders is expected to be the dominant factor driving the global seize treatment market over the forecast period. Market Ana…